Search results for

Donald Trump drew more working-class voters to the GOP than any president since Ronald Reagan. Now Republicans are trying to maintain that Trump appeal without Trump on the ballot in 2022.

The Atlantic Coast Conference decided to pull many post-season tournaments out of North Carolina this season due to a controversial state law. This move follows the NCAA decision to remove college championship games out of the state.

The chair of the House select committee investigating the Jan. 6 attack says by month's end they'll ask former Vice President Mike Pence to testify. They may also request testimony from Ivanka Trump.

Many Republican allies of former President Trump were outraged in 2021 when the Capitol was attacked. But as Trump's popularity endures, the party's elected leaders now largely overlook Jan. 6.

Rapid COVID-19 tests are in short supply and prices are increasing. The Supreme Court will review two of Biden's vaccine rules for workers. Not many Republicans attended Jan. 6 events on Capitol Hill.

A COVID-19 booster study suggests Moderna or Pfizer works best. A House panel investigating the U.S. Capitol attack issues more subpoenas. The Biden administration aims to break up shipping logjams.

Fans who danced to "Paper Planes" might hardly recognize the conspiracy-touting artist before them today — but in a certain way, she's the same button-pusher as ever.

In Stuart's new novel John of John, both father and son are gay. David Bianculli reviews the TV adaptation of Lord of the Flies. Baby Reindeer creator Richard Gadd discusses his new series Half Man.

A year after the attack on the Capitol, there's a growing realization that traditional tools to counter extremism in the U.S. may not apply.

NPR's Steve Inskeep speaks to AP correspondent Sarah El Deeb about how people in Beirut are reacting to street violence that left six people dead.

No deaths were reported in tests, and there were no signs of myocarditis, or heart inflammation, as a side effect.

Moderna says its low-dose pediatric vaccine appears to be safe and provide protection for kids ages 6 months to 6 years, and it is asking the Food and Drug Administration for emergency authorization.